Apnimed, Inc. (APMD) vs Candel Therapeutics, Inc. (CADL)

A side-by-side comparison of Apnimed, Inc. and Candel Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

APMD

Apnimed, Inc.

$752M

$18.89HealthcareDelayed quote: Oct 6, 2026, 3:10 PM EDT

CADL

Candel Therapeutics, Inc.

$737M

$10.06HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT

Total return — APMD vs CADL

growth of $100 · dividends reinvested · last 1y

APMD +35.9% (+35.9%/yr)CADL +8.8% (+8.8%/yr)APMD compounded faster over this window

APMD CADL

Metrics side by side

Total return (annualized)

Metric	APMD	CADL
Total return (1Y)	N/A	83.46%
Total return CAGR (3Y)	N/A	128.23%
Total return CAGR (5Y)	N/A	-1.42%

APMD is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full APMD analysis Full CADL analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.